{"id":23019,"date":"2024-06-28T09:10:42","date_gmt":"2024-06-28T13:10:42","guid":{"rendered":"https:\/\/medicarereport.org\/?p=23019"},"modified":"2024-06-28T09:10:43","modified_gmt":"2024-06-28T13:10:43","slug":"fda-approves-1st-inhaled-copd-treatment-in-20-years","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=23019","title":{"rendered":"FDA approves 1st inhaled COPD treatment in 20 years"},"content":{"rendered":"\n<p>(By Ashleigh Hollowell for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n\n\n\n<p>An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26, drugmaker Verona Pharma announced.<\/p>\n\n\n\n<p>It is the first FDA-approved treatment for COPD in more than two decades, according to the release.  Continue reading <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/fda-approves-1st-inhaled-copd-treatment-in-20-years.html\" data-type=\"link\" data-id=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/fda-approves-1st-inhaled-copd-treatment-in-20-years.html\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"152\" class=\"wp-image-7883\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo3.jpg\" alt=\"\"><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Ashleigh Hollowell for Becker&#8217;s Hospital Review) An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[1396,76,1398,1397],"class_list":["post-23019","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs","tag-copd","tag-fda","tag-inhaled-treatment","tag-verona-pharma"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23019"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23019\/revisions"}],"predecessor-version":[{"id":23020,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/23019\/revisions\/23020"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}